2010Chongqing yixueRequires access

Adenosine triphosphate and propafenone treat paroxysmal supraventricular tachycardia in emergency room:a randomized controlled trial

Xia Li

Open publisher page 0 citations

Abstract

Objective To evaluate the therapy effect of adenosine triphosphate and propafenone to paroxysmal supraventricular tachycardia in emergency room.Methods One hundred and seventy-three patients who were diagnosed paroxysmal supraventricular tachycardia were randomly separated into group ATP(n=86) and group propafenone(n=87).The achievement ratio,time of conversion,side effects of two drugs were compared.Results The time of conversion in group ATP and group propafenone was 0.92±0.38min and 33.00±17.00min respectively(P0.01).The achievement ratio in group ATP was 97.7% and 88.5% in group propafenone (P0.05).More mild side effects were recorded in group ATP(37.2% vs 11.5%,P0.01),whereas more severe side effects were discovered in group propafenone(4.6% vs 1.2%,P0.05).Conclusion Treat PSVT with ATP or propafenone can get a highly achievement ratio.Although ATP has more mild side effects in cardioversion,it has more safety and more successful than propafenone.

About this research paper

What this paper is about

Objective To evaluate the therapy effect of adenosine triphosphate and propafenone to paroxysmal supraventricular tachycardia in emergency room.Methods One hundred and seventy-three patients who were diagnosed paroxysmal supraventricular tachycardia were randomly separated into group ATP(n=86) and group propafenone(n=87).The achievement ratio,time of conversion,side effects of two drugs were compared.Results The time of conversion in group ATP and group propafenone was 0.92±0.38min and 33.00±17.00min respectively(P0.01).The achievement ratio in group ATP was 97.7% and 88.5% in group propafenone (P0.05).More mild side effects were recorded in group ATP(37.2% vs 11.5%,P0.01),whereas more severe side effects were discovered in group propafenone(4.6% vs 1.2%,P0.05).Conclusion Treat PSVT with ATP or propafenone can get a highly achievement ratio.Although ATP has more mild side effects in cardioversion,it has more safety and more successful than propafenone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the therapy effect of adenosine triphosphate and propafenone to paroxysmal supraventricular tachycardia in emergency room.Methods One hundred and seventy-three patients who were diagnosed paroxysmal supraventricular tachycardia were randomly separated into group ATP(n=86) and group propafenone(n=87).The achievement ratio,time of conversion,side effects of two drugs were compared.Results The time of conversion in group ATP and group propafenone was 0.92±0.38min and 33.00±17.00min respectively(P0.01).The achievement ratio in group ATP was 97.7% and 88.5% in group propafenone (P0.05).More mild side effects were recorded in group ATP(37.2% vs 11.5%,P0.01),whereas more severe side effects were discovered in group propafenone(4.6% vs 1.2%,P0.05).Conclusion Treat PSVT with ATP or propafenone can get a highly achievement ratio.Although ATP has more mild side effects in cardioversion,it has more safety and more successful than propafenone.

Key concepts: Propafenone, Medicine, Paroxysmal supraventricular tachycardia, Supraventricular tachycardia, Anesthesia, Adenosine triphosphate, Tachycardia, Side effect (computer science)

Related papers

Back to paper searchBrowse research topicsOriginal source
Adenosine triphosphate and propafenone treat paroxysmal supraventricular tachycardia in emergency room:a randomized controlled trial — Research Paper | ScholarLens